dactinomycin has been researched along with Diarrheogenic Islet Cell Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchanan, KD; Cantwell, B; Collins, PG; Fennelly, JJ; Fielding, JF; FitzGerald, O | 1 |
| Buchanan, KD; Courtney, MG; Fielding, JF; Holloway, H; Lane, BE; Leavey, SF; Royston, D | 1 |
1 review(s) available for dactinomycin and Diarrheogenic Islet Cell Tumor
| Article | Year |
|---|---|
Pancreatic vipomas: spectrum of presentation and evolution of diagnostic and therapeutic modalities.
Topics: Combined Modality Therapy; Dactinomycin; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Prednisolone; Vasoactive Intestinal Peptide; Vipoma | 1995 |
1 other study(ies) available for dactinomycin and Diarrheogenic Islet Cell Tumor
| Article | Year |
|---|---|
Metastatic pancreatic vipoma: a case report of clinical response following treatment with corticosteroids and actinomycin D.
Topics: Adenoma, Islet Cell; Dactinomycin; Female; Humans; Indomethacin; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Prednisolone; Vasoactive Intestinal Peptide; Vipoma | 1982 |